""
UC Davis Medicine Logo
The institution's principal publication for alumni, friends and physicians.
""
Horizontal boundary
""
""
"" "" ""
  N E W S  
"" "" ""
"" 'Best Hospital' in four specialties ""
""

""
"" New Birth Defect Expert ""
""

""
"" Tumor response may not be best measure ""
""

""
  Assessment of children with autism launched  
""

""
  New drug extends lung cancer survival  
""

""
  Grape seed extract may reduce blood pressure  
""

""
  Thimerosal linked with immune system dysfunction  
     
  Apples' protective ways identified  
     
  Molecule that targets leukemia, lymphoma cells found  
     
  Better, safer test for pernicious anemia  
     
  Smoking impact on Asians greater than realized  
     
  Bariatric program awarded center of excellence  
     
  Telemedicine program honored  
Vertical Seperator Line
""
""
NEWS
""
""
"" ""
"" ""
 
""

Molecule that targets leukemia, lymphoma cells found

 "" PHOTO — Professor Kit Lam
  ""
Professor Kit Lam
"" ""

UC Davis Cancer Center researchers have developed a novel peptide that binds to the surface of leukemia and lymphoma cells with extremely high affinity, specificity and stability, and demonstrates remarkable promise as a tool to help image tumors and deliver anti-cancer drugs. The research was reported in Nature Chemical Biology. Kit Lam, professor and chief of hematology and oncology at UC Davis Cancer Center and senior author of the paper, says this peptide has great potential for becoming a new, effective imaging and therapeutic agent for patients with lymphoid cancers.

""
"" ""
 
"" ""
"" ""
Vertical Seperator Line
"" "" ""
     
"" "" Vertical Seperator Line "" "" "" ""
"" "" Vertical Seperator Line
""
""

UC DAVIS SCHOOL OF MEDICINE
PUBLIC AFFAIRS
4900 Broadway, Suite #1200
Sacramento, CA 95820

ucdavismedicine@ucdmc.ucdavis.edu

© 2006 UC Regents. All Rights Reserved.

"" "" ""